A detailed history of Gradient Investments LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Gradient Investments LLC holds 7,136 shares of AZN stock, worth $548,044. This represents 0.01% of its overall portfolio holdings.

Number of Shares
7,136
Previous 7,335 2.71%
Holding current value
$548,044
Previous $494,000 2.23%
% of portfolio
0.01%
Previous 0.01%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 23, 2024

SELL
$61.03 - $69.57 $12,144 - $13,844
-199 Reduced 2.71%
7,136 $483,000
Q4 2023

Jan 18, 2024

BUY
$61.89 - $69.28 $4,703 - $5,265
76 Added 1.05%
7,335 $494,000
Q3 2023

Oct 27, 2023

BUY
$64.85 - $71.7 $10,959 - $12,117
169 Added 2.38%
7,259 $491,000
Q2 2023

Jul 11, 2023

SELL
$69.91 - $75.81 $30,900 - $33,508
-442 Reduced 5.87%
7,090 $507,000
Q1 2023

Apr 17, 2023

BUY
$63.15 - $71.6 $1,515 - $1,718
24 Added 0.32%
7,532 $522,000
Q4 2022

Jan 10, 2023

SELL
$54.21 - $70.44 $15,829 - $20,568
-292 Reduced 3.74%
7,508 $0
Q3 2022

Oct 14, 2022

SELL
$53.02 - $135.75 $53,550 - $137,107
-1,010 Reduced 11.46%
7,800 $428,000
Q2 2022

Jul 11, 2022

SELL
$59.26 - $71.14 $10,785 - $12,947
-182 Reduced 2.02%
8,810 $582,000
Q1 2022

May 26, 2022

SELL
$55.72 - $67.12 $34,212 - $41,211
-614 Reduced 6.39%
8,992 $597,000
Q4 2021

Jan 12, 2022

SELL
$54.02 - $63.83 $25,929 - $30,638
-480 Reduced 4.76%
9,606 $560,000
Q3 2021

Oct 18, 2021

SELL
$55.56 - $60.79 $22,390 - $24,498
-403 Reduced 3.84%
10,086 $606,000
Q2 2021

Jul 12, 2021

SELL
$48.42 - $60.18 $19,319 - $24,011
-399 Reduced 3.66%
10,489 $628,000
Q1 2021

Apr 21, 2021

BUY
$47.16 - $54.44 $2,216 - $2,558
47 Added 0.43%
10,888 $541,000
Q4 2020

Jan 08, 2021

SELL
$48.52 - $58.02 $52,789 - $63,125
-1,088 Reduced 9.12%
10,841 $594,000
Q3 2020

Oct 06, 2020

SELL
$53.07 - $61.1 $63,259 - $72,831
-1,192 Reduced 9.08%
11,929 $654,000
Q2 2020

Jul 10, 2020

SELL
$43.1 - $55.31 $756,146 - $970,358
-17,544 Reduced 57.21%
13,121 $694,000
Q1 2020

Apr 07, 2020

SELL
$37.79 - $51.33 $103,846 - $141,054
-2,748 Reduced 8.22%
30,665 $1.37 Million
Q4 2019

Jan 15, 2020

SELL
$42.46 - $50.46 $120,798 - $143,558
-2,845 Reduced 7.85%
33,413 $1.67 Million
Q3 2019

Oct 10, 2019

SELL
$40.12 - $45.47 $342,384 - $388,040
-8,534 Reduced 19.05%
36,258 $1.62 Million
Q2 2019

Jul 16, 2019

BUY
$37.28 - $41.68 $620,078 - $693,263
16,633 Added 59.07%
44,792 $1.85 Million
Q1 2019

Apr 11, 2019

BUY
$35.49 - $43.02 $990,845 - $1.2 Million
27,919 Added 11632.92%
28,159 $1.14 Million
Q4 2018

Jan 18, 2019

SELL
$36.86 - $41.49 $5,418 - $6,099
-147 Reduced 37.98%
240 $9,000
Q3 2018

Oct 11, 2018

SELL
$34.76 - $39.72 $10,323 - $11,796
-297 Reduced 43.42%
387 $15,000
Q1 2018

Apr 11, 2018

BUY
$32.97 - $36.63 $19,254 - $21,391
584 Added 584.0%
684 $24,000
Q4 2017

Feb 07, 2018

BUY
$32.09 - $34.78 $3,209 - $3,478
100
100 $3,000

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $238B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Gradient Investments LLC Portfolio

Follow Gradient Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gradient Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gradient Investments LLC with notifications on news.